Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity?

doi:10.4329/wjr.v4.i5.220

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4344)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

480

HTML

3181

Figures (1-1)

471

Tables (1-1)

212

Sum=4344

May 28, 2012 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (42)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Radiol. May 28, 2012; 4(5): 220-223
Published online May 28, 2012. doi: 10.4329/wjr.v4.i5.220

Full Size Figure Download Figure

Figure 1 Significant increase in cardiac fluorodeoxyglucose uptake in post-adriamycin treatment (on right) fluorodeoxyglucose positron emission tomography scan compared to pre-treatment fluorodeoxyglucose positron emission tomography scan (on left).

Citation: Borde C, Kand P, Basu S. Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity? World J Radiol 2012; 4(5): 220-223
URL: https://www.wjgnet.com/1949-8470/full/v4/i5/220.htm
DOI: https://dx.doi.org/10.4329/wjr.v4.i5.220